EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral Activity of Marine Bacterium Paraliobacillus zengyii Against Enterovirus 71 In Vitro and In Vivo

Qianjin Fan, Haoyue Huangfu, Lan Chen, Mengqi Jiao, Beijie Li, Zhijie Cao iD, Hui Sun, Xuelian Luo, Jianguo Xu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Qianjin Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Public Health, School of Medicine, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: Enterovirus A, Human, Antiviral Agents, Probiotics, Enterovirus Infections. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Research Units of Discovery of Unknown Bacteria and Function, the National Key Laboratory of Intelligent Tracking, Forecasting for Infectious Diseases (NITFID) of China CDC, the trend, respond and prediction for the third major transition of human infectious disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterovirus 71 (EV71) is the major causative agent of hand, foot, and mouth disease (HFMD), leading to a serious health threat to young children. Probiotics are effective at treating or preventing gastrointestinal infections, especially viral infections. Probiotics against EV71 are mainly traditional lactic acid-producing bacteria, and most of them have been proven to be effective only in vitro. Here, we report that the marine bacterium Paraliobacillus zengyii X-1125 (P. zengyii) has promising anti-EV71 activity. The antiviral effect of P. zengyii against EV71 was assessed in different cell lines, and the viral RNA levels and titers were obviously reduced after treatment with P. zengyii. Furthermore, we established an EV71-infected mouse model to evaluate its antiviral efficacy in vivo. The oral administration of P. zengyii significantly decreased the viral loads in the hindlimb muscles, spleens, and ileums. Further research revealed that P. zengyii enhances the expression of type I interferon (IFN-I) in EV71-infected cells. Similarly, transcriptome analysis indicated that the expression of interferon-stimulated genes (ISGs) in EV71-infected mice significantly increased after P. zengyii treatment. Taken together, the results of this study indicated that P. zengyii markedly reduces EV71 infection by regulating the IFN response both in vivo and in vitro, providing a potential means to work against EV71 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterovirus A, HumanAntiviral AgentsProbioticsEnterovirus InfectionsHand, Foot and Mouth DiseaseAnimalsMiceHumansDisease Models, AnimalInterferon Type ICell LineViral Load

Stichwörter der Autor:innen

IFN responseParaliobacillus zengyiiantiviral activityenterovirus 71mouse model

Substanzen

Antiviral AgentsInterferon Type I

Autor:innen und Institutionen

  • Institute of Public Health, School of Medicine, Nankai University, Tianjin 300071, China.
  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102…
  • Center of Reverse Microbial Etiology, School of Public Health, Shanxi Medical University, Taiyuan 030001, China.
  • Research Unite for Unknown Microbe, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

ORCID-Profile: Zhijie Cao

Förderung

  • the Research Units of Discovery of Unknown Bacteria and Function
  • the National Key Laboratory of Intelligent Tracking, Forecasting for Infectious Diseases (NITFID) of China CDC
  • the trend, respond and prediction for the third major transition of human infectious disease
  • National Key Laboratory of Intelligent Tracking, Forecasting for Infectious Diseases (NITFID) of China CDC
  • Research Units of Discovery of Unknown Bacteria and Function
  • trend, respond, and prediction for the third major transition of human infectious disease (2024–2025)

Zitieren

APA

Fan, Q., Huangfu, H., Chen, L., Jiao, M., Li, B., Cao, Z., Sun, H., Luo, X., & Xu, J. (2025). Antiviral Activity of Marine Bacterium Paraliobacillus zengyii Against Enterovirus 71 In Vitro and In Vivo. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083500

Vancouver

Fan Q, Huangfu H, Chen L, Jiao M, Li B, Cao Z, et al. Antiviral Activity of Marine Bacterium Paraliobacillus zengyii Against Enterovirus 71 In Vitro and In Vivo. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083500

BibTeX
@article{Fan2025,
  author = {Fan, Qianjin and Huangfu, Haoyue and Chen, Lan and Jiao, Mengqi and Li, Beijie and Cao, Zhijie and Sun, Hui and Luo, Xuelian and Xu, Jianguo},
  title = {Antiviral Activity of Marine Bacterium Paraliobacillus zengyii Against Enterovirus 71 In Vitro and In Vivo},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083500}
}
Kostenlos starten →